Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.51 0.3  3.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £250.8m
Enterprise Value £87.3m
Revenue £n/a
Position in Universe 4090th / 7008

BUZZ-Fusion Pharma: Up on AstraZeneca partnership to develop cancer therapies

Mon 2nd November, 2020 1:00pm
** Drug developer's shares  FUSN.O  rise 15.7% to $14.35
premarket, making it the third-biggest pct gainer across U.S.
exchanges
    ** FUSN partners with AstraZeneca PLC  AZN.L  to develop and
sell combination therapies for cancer  urn:newsml:reuters.com:*:nPn381Ff9a
    ** Collaboration will use FUSN's lead targeted alpha
therapies candidate FPI-1434 and AZN's therapeutics; both cos to
retain full rights to their respective assets
    ** Agreement includes an upfront payment from AZN, as well
as future development milestone and other payments
    ** FUSN down 27% since it started trading in June

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.